EVC2 p.Ala386Pro
c.1156G>C · VCV4251542
Computational evidence
| Protein change | ||
| AlphaMissense | 0.8087 | likely pathogenic · top 3% in EVC2 |
|---|---|---|
| REVEL | 0.447 | indeterminate |
| SaProt | LLR -9.90 | tolerated |
| ⇒ AlphaMissense calls this damaging; SaProt does not; REVEL is indeterminate. | ||
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
| Constraint at this position | ||
| Conservation | phyloP 3.7 | GERP 1.3, phastCons 1 |
| Regional constraint | o/e 1.14 | unconstrained · MANE · 146 kb · p 1.9e-08 · regional, not allelic |
| Overall | ||
| CADD | 24.3 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| European (non-Finnish)grpmax | 0.00212% | 47,201 |
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,486 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- EVC2
- Protein
- p.Ala386Pro
- Coding
- c.1156G>C
- MANE Select
- NM_147127
- Type
- single nucleotide variant
- Location
- chr4:5640828 (GRCh38)
- Gene constraint
- LOEUF 1.092 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 73.33
Similar variants
- EVC2 p.Gln1089Ter Pathogenic ★★ same condition
- EVC2 p.Ala1132Val Uncertain significance ★★ ⚠ same condition
- EVC2 p.Ala1150Asp Uncertain significance ★★ ⚠ same condition
- EVC2 p.Ala1260Val Uncertain significance ★★ ⚠ same condition
- EVC2 p.Ala618Thr Uncertain significance ★★ ⚠ same condition
- EVC2 p.Ala703Val Uncertain significance ★★ ⚠ same condition
- EVC2 p.Arg1140Cys Uncertain significance ★★ ⚠ same condition
- EVC2 p.Arg1141Trp Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/evc2-p-ala386pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown